163 related articles for article (PubMed ID: 34649337)
1. Jiangzhi Granule attenuates non-alcoholic steatohepatitis by suppressing TNF/NFκB signaling pathway-a study based on network pharmacology.
Zhou W; Zhu Z; Xiao X; Li C; Zhang L; Dang Y; Ge G; Ji G; Zhu M; Xu H
Biomed Pharmacother; 2021 Nov; 143():112181. PubMed ID: 34649337
[TBL] [Abstract][Full Text] [Related]
2. An herbal formulation "Shugan Xiaozhi decoction" ameliorates methionine/choline deficiency-induced nonalcoholic steatohepatitis through regulating inflammation and apoptosis-related pathways.
Wang S; Chen B; Du R; Zhong M; Zhang C; Jin X; Cui X; Zhou Y; Kang Q; Xu H; Li Y; Wu Q; Tong G; Luo L
J Ethnopharmacol; 2024 Jul; 329():118127. PubMed ID: 38583728
[TBL] [Abstract][Full Text] [Related]
3. Uncovering the mechanism of Huanglian-Wuzhuyu herb pair in treating nonalcoholic steatohepatitis based on network pharmacology and experimental validation.
Zhang X; Gao R; Zhou Z; Sun J; Tang X; Li J; Zhou X; Shen T
J Ethnopharmacol; 2022 Oct; 296():115405. PubMed ID: 35644437
[TBL] [Abstract][Full Text] [Related]
4. Macrophage p38α promotes nutritional steatohepatitis through M1 polarization.
Zhang X; Fan L; Wu J; Xu H; Leung WY; Fu K; Wu J; Liu K; Man K; Yang X; Han J; Ren J; Yu J
J Hepatol; 2019 Jul; 71(1):163-174. PubMed ID: 30914267
[TBL] [Abstract][Full Text] [Related]
5. Cangju Qinggan Jiangzhi Decoction Reduces the Development of NonAlcoholic Steatohepatitis and Activation of Kupffer Cells.
Cheng Y; Chen T; Ping J; Chen J
Cell Physiol Biochem; 2018; 48(3):971-982. PubMed ID: 30036865
[TBL] [Abstract][Full Text] [Related]
6. Jiangzhi granule attenuates non-alcoholic steatohepatitis through modulating bile acid in mice fed high-fat vitamin D deficiency diet.
Cao Y; Shu X; Li M; Yu S; Li C; Ji G; Zhang L
Biomed Pharmacother; 2022 May; 149():112825. PubMed ID: 35305348
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs.
Wang H; Tan H; Zhan W; Song L; Zhang D; Chen X; Lin Z; Wang W; Yang Y; Wang L; Bei W; Guo J
J Ethnopharmacol; 2021 Jun; 274():114056. PubMed ID: 33771638
[TBL] [Abstract][Full Text] [Related]
8. Compound Shouwu Jiangzhi Granule regulates triacylglyceride synthesis to alleviate hepatic lipid accumulation.
Qian F; Ouyang B; Cai Z; Zhu D; Yu S; Zhao J; Wei N; Wang G; Wang L; Zhang J
Phytomedicine; 2024 Jul; 129():155691. PubMed ID: 38744232
[TBL] [Abstract][Full Text] [Related]
9. Identify Molecular Mechanisms of Jiangzhi Decoction on Nonalcoholic Fatty Liver Disease by Network Pharmacology Analysis and Experimental Validation.
Wang L; Zhi Y; Ye Y; Zhang M; Ma X; Tie H; Ma X; Zheng N; Xia W; Song Y
Biomed Res Int; 2020; 2020():8829346. PubMed ID: 33415161
[TBL] [Abstract][Full Text] [Related]
10. Exploring and Verifying the Mechanism and Targets of Shenqi Pill in the Treatment of Nonalcoholic Steatohepatitis via Network Pharmacology and Experiments.
He B; Chen Z; Nie Y; Luo M; Xu S; Yan J; Chen Z
J Immunol Res; 2022; 2022():6588144. PubMed ID: 35733920
[TBL] [Abstract][Full Text] [Related]
11. A network pharmacology approach: Inhibition of the NF-κB signaling pathway contributes to the NASH preventative effect of an Oroxylum indicum seed extract in oleic acid-stimulated HepG2 cells and high-fat diet-fed rats.
Sun W; Liu P; Yang B; Wang M; Wang T; Sun W; Wang X; Zheng W; Song X; Li J
Phytomedicine; 2021 Jul; 88():153498. PubMed ID: 33640247
[TBL] [Abstract][Full Text] [Related]
12. Prediction and verification of the active ingredients and potential targets of Erhuang Quzhi Granules on non-alcoholic fatty liver disease based on network pharmacology.
Li S; Wu X; Ma Y; Zhang H; Chen W
J Ethnopharmacol; 2023 Jul; 311():116435. PubMed ID: 37023836
[TBL] [Abstract][Full Text] [Related]
13. BMP9 promotes methionine- and choline-deficient diet-induced nonalcoholic steatohepatitis in non-obese mice by enhancing NF-κB dependent macrophage polarization.
Jiang Q; Li Q; Liu B; Li G; Riedemann G; Gaitantzi H; Breitkopf-Heinlein K; Zeng A; Ding H; Xu K
Int Immunopharmacol; 2021 Jul; 96():107591. PubMed ID: 33812253
[TBL] [Abstract][Full Text] [Related]
14. Effect of curcumin on the non-alcoholic steatohepatitis via inhibiting the M1 polarization of macrophages.
Tong C; Wu H; Gu D; Li Y; Fan Y; Zeng J; Ding W
Hum Exp Toxicol; 2021 Dec; 40(12_suppl):S310-S317. PubMed ID: 34470535
[TBL] [Abstract][Full Text] [Related]
15. Integrating transcriptomics and network pharmacology to reveal the mechanisms of total Rhizoma Coptidis alkaloids against nonalcoholic steatohepatitis.
Li J; Ma Z; Yang Z; Yang M; Li C; Li M; Li X; Chen X; Ma H; Chen W; Ye X; Li X
J Ethnopharmacol; 2024 Mar; 322():117600. PubMed ID: 38103844
[TBL] [Abstract][Full Text] [Related]
16. CD44 is a key player in non-alcoholic steatohepatitis.
Patouraux S; Rousseau D; Bonnafous S; Lebeaupin C; Luci C; Canivet CM; Schneck AS; Bertola A; Saint-Paul MC; Iannelli A; Gugenheim J; Anty R; Tran A; Bailly-Maitre B; Gual P
J Hepatol; 2017 Aug; 67(2):328-338. PubMed ID: 28323124
[TBL] [Abstract][Full Text] [Related]
17. Blockade of C5aR1 alleviates liver inflammation and fibrosis in a mouse model of NASH by regulating TLR4 signaling and macrophage polarization.
Jiang K; Lu S; Li D; Liu M; Jin H; Lei B; Wang S; Long K; He S; Zhong F
J Gastroenterol; 2023 Sep; 58(9):894-907. PubMed ID: 37227481
[TBL] [Abstract][Full Text] [Related]
18. Iron alters macrophage polarization status and leads to steatohepatitis and fibrogenesis.
Handa P; Thomas S; Morgan-Stevenson V; Maliken BD; Gochanour E; Boukhar S; Yeh MM; Kowdley KV
J Leukoc Biol; 2019 May; 105(5):1015-1026. PubMed ID: 30835899
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol prevents liver damage in MCD-induced steatohepatitis mice by promoting SIGIRR gene transcription.
Che Y; Shi X; Zhong X; Zhang Y; Si R; Li Y; Shi Y
J Nutr Biochem; 2020 Aug; 82():108400. PubMed ID: 32438122
[TBL] [Abstract][Full Text] [Related]
20. Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice.
Xu B; Jiang M; Chu Y; Wang W; Chen D; Li X; Zhang Z; Zhang D; Fan D; Nie Y; Shao F; Wu K; Liang J
J Hepatol; 2018 Apr; 68(4):773-782. PubMed ID: 29273476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]